Source: Eur Respir J 2008; 31: 1145-1147
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Lahzami S., King G. G.. Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment. Eur Respir J 2008; 31: 1145-1147

Member's Comments

No comment yet.

Related content which might interest you: Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 Induced sputum in children with persistent asthma: the effect of inhaled corticosteroid treatment Source: Eur Respir J 2006; 28: Suppl. 50, 258s Year: 2006 Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness Source: Eur Respir J 2006; 27: 1144-1151 Year: 2006 Repeated inhaled airway allergen challenge model in asthma Source: Annual Congress 2009 - Inflammation and airways Year: 2009 Assessment of maximal airway response before and after inhaled corticosteriod treatment in new diagnosed asthma patients Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Pharmacogenetics of inhaled corticosteroid response in adults with asthma Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006 Small airway function in asthma patients treated with an ultrafine inhaled steroid aerosol Source: Eur Respir J 2004; 24: Suppl. 48, 581s Year: 2004 Small airways targeting of inhaled steroids for severe therapy resistant asthma in children Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015 The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002 Is there a problem with inhaled corticosteroid use in COPD? Source: Virtual Congress 2020 – Airway diseases Year: 2020 Bronchial cell infiltrate after two weeks, repeated low-dose allergen exposure in atopic asthma: protection by inhaled steroids? Source: Eur Respir J 2002; 20: Suppl. 38, 588s Year: 2002 Children with mild asthma: do they benefit from inhaled corticosteroids? Source: Eur Respir J 2002; 20: 1470-1475 Year: 2002 Refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation: is this phenomenon airway remodeling? Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 A comparison of two allergen challenge methods in asthmatics using inhaled corticosteroids Source: Annual Congress 2013 –New issues in lung function testing Year: 2013 Hypertonic histamine challenge induced cough in assessing the treatment response to inhaled corticosteroid in asthma Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008 Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial Source: Eur Respir J 2007; 30: 457-466 Year: 2007 Induced sputum in children with mild-moderate persistent asthma: the effect of inhaled corticosteroid treatment Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Effects of intervention with high-dose inhaled corticosteroids on airway remodelling in diagnosed genetic variants of IL13 with asthma Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010